Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 2/2012

01-04-2012 | Research Article

Impact of a region wide antimicrobial stewardship guideline on urinary tract infection prescription patterns

Authors: Celine Slekovec, Joël Leroy, Nathalie Vernaz-Hegi, Jean-Pierre Faller, Danièle Sekri, Bruno Hoen, Daniel Talon, Xavier Bertrand

Published in: International Journal of Clinical Pharmacy | Issue 2/2012

Login to get access

Abstract

Background Fluoroquinolones are frequently prescribed for non complicated urinary tract infection treatments and have a negative ecological impact. We aimed to substitute them by antibiotics with narrower activity spectrum in order to preserve fluoroquinolone activity in complicated hospital infections. Objective To assess the impact of a multi-modal approach that combines the dispatching of antibiotic prescription guidelines and voluntary attendance at educational sessions on general practitioners’ (GP) antibiotic prescription habits. Setting This study was led in Franche-Comté, a French eastern region, where GPs were given a guideline recommending a restricted use of fluoroquinolones for urinary tract infections. Method Segmented regression analysis of interrupted time series was used to assess changes in antibiotic prescription. Main outcome measure: The antibiotic prescription data of nitrofurantoin, fosfomycin-trometamol and fluoroquinolones for women aged 15–65 years were obtained from the regional agency of health insurance. Results Twenty months after intervention, the number of nitrofurantoin and fosfomycintrometamol prescriptions increased by 36.8% (95% CI: 30.6–42.2) and 28.5% (95% CI: 22.9–35.4), respectively, while that of norfloxacin decreased by 9.1% (95% CI: −15.3 to −3.5). Conclusion This study suggests that the dispatch of the guideline on urinary tract infection had a moderate impact on antibiotic prescriptions.
Literature
1.
go back to reference Lautenbach E, Fishman NO, Bilker WB, Castiglioni A, Metlay JP, Edelstein PH, et al. Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Arch Intern Med. 2002;162(21):2469–77.PubMedCrossRef Lautenbach E, Fishman NO, Bilker WB, Castiglioni A, Metlay JP, Edelstein PH, et al. Risk factors for fluoroquinolone resistance in nosocomial Escherichia coli and Klebsiella pneumoniae infections. Arch Intern Med. 2002;162(21):2469–77.PubMedCrossRef
2.
go back to reference Zervos MJ, Hershberger E, Nicolau DP, Ritchie DJ, Blackner LK, Coyle EA, et al. Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991–2000. Clin Infect Dis. 2003;37(12):1643–8.PubMedCrossRef Zervos MJ, Hershberger E, Nicolau DP, Ritchie DJ, Blackner LK, Coyle EA, et al. Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991–2000. Clin Infect Dis. 2003;37(12):1643–8.PubMedCrossRef
3.
go back to reference Charbonneau P, Parienti JJ, Thibon P, Ramakers M, Daubin C, du Cheyron D, et al. Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study. Clin Infect Dis. 2006;42(6):778–84.PubMedCrossRef Charbonneau P, Parienti JJ, Thibon P, Ramakers M, Daubin C, du Cheyron D, et al. Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study. Clin Infect Dis. 2006;42(6):778–84.PubMedCrossRef
4.
go back to reference Muller A, Mauny F, Talon D, Donnan PT, Harbarth S, Bertrand X. Effect of individual- and group-level antibiotic exposure on MRSA isolation: a multilevel analysis. J Antimicrob Chemother. 2006;58(4):878–81.PubMedCrossRef Muller A, Mauny F, Talon D, Donnan PT, Harbarth S, Bertrand X. Effect of individual- and group-level antibiotic exposure on MRSA isolation: a multilevel analysis. J Antimicrob Chemother. 2006;58(4):878–81.PubMedCrossRef
5.
go back to reference Stone SP, Cooper BS, Kibbler CC, Cookson BD, Roberts JA, Medley GF, et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect Dis. 2007;7(4):282–8.PubMedCrossRef Stone SP, Cooper BS, Kibbler CC, Cookson BD, Roberts JA, Medley GF, et al. The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection. Lancet Infect Dis. 2007;7(4):282–8.PubMedCrossRef
6.
go back to reference World Health Organization (WHO). Anatomic therapeutic chemical (ATC) classification index with defined daily doses (DDDs). WHO, Oslo, Norway; 2001. World Health Organization (WHO). Anatomic therapeutic chemical (ATC) classification index with defined daily doses (DDDs). WHO, Oslo, Norway; 2001.
7.
go back to reference Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299–309.PubMedCrossRef Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299–309.PubMedCrossRef
8.
go back to reference Ansari F, Gray K, Nathwani D, Phillips G, Ogston S, Ramsay C, et al. Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J Antimicrob Chemother. 2003;52(5):842–8.PubMedCrossRef Ansari F, Gray K, Nathwani D, Phillips G, Ogston S, Ramsay C, et al. Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis. J Antimicrob Chemother. 2003;52(5):842–8.PubMedCrossRef
9.
go back to reference Mahamat A, MacKenzie FM, Brooker K, Monnet DL, Daures JP, Gould IM. Impact of infection control interventions and antibiotic use on hospital MRSA: a multivariate interrupted time-series analysis. Int J Antimicrob Agents. 2007;30(2):169–76.PubMedCrossRef Mahamat A, MacKenzie FM, Brooker K, Monnet DL, Daures JP, Gould IM. Impact of infection control interventions and antibiotic use on hospital MRSA: a multivariate interrupted time-series analysis. Int J Antimicrob Agents. 2007;30(2):169–76.PubMedCrossRef
10.
go back to reference Apisarnthanarak A, Pinitchai U, Thongphubeth K, Yuekyen C, Warren DK, Zack JE, et al. Effectiveness of an educational program to reduce ventilator-associated pneumonia in a tertiary care center in Thailand: a 4-year study. Clin Infect Dis. 2007;45(6):704–11.PubMedCrossRef Apisarnthanarak A, Pinitchai U, Thongphubeth K, Yuekyen C, Warren DK, Zack JE, et al. Effectiveness of an educational program to reduce ventilator-associated pneumonia in a tertiary care center in Thailand: a 4-year study. Clin Infect Dis. 2007;45(6):704–11.PubMedCrossRef
11.
go back to reference Matowe L, Ramsay CR, Grimshaw JM, Gilbert FJ, Macleod MJ, Needham G. Effects of mailed dissemination of the Royal College of Radiologists’guidelines on general practitioner referrals for radiography: a time series analysis. Clin Radiol. 2002;57(7):575–8.PubMedCrossRef Matowe L, Ramsay CR, Grimshaw JM, Gilbert FJ, Macleod MJ, Needham G. Effects of mailed dissemination of the Royal College of Radiologists’guidelines on general practitioner referrals for radiography: a time series analysis. Clin Radiol. 2002;57(7):575–8.PubMedCrossRef
12.
go back to reference J Leroy, I Patry, C Faure, E Ariskina, JP Gaume, T Henon, et al. [Regional audit on fluoroquinolones usage in the hospital and the community: Are these antibiotics over-used?]. Pathol Biol (Paris), 2011;59(5):103–7. J Leroy, I Patry, C Faure, E Ariskina, JP Gaume, T Henon, et al. [Regional audit on fluoroquinolones usage in the hospital and the community: Are these antibiotics over-used?]. Pathol Biol (Paris), 2011;59(5):103–7.
13.
go back to reference Chomarat M. Resistance of bacteria in urinary tract infections. Int J Antimicrob Agents. 2000;16(4):483–7.PubMedCrossRef Chomarat M. Resistance of bacteria in urinary tract infections. Int J Antimicrob Agents. 2000;16(4):483–7.PubMedCrossRef
14.
go back to reference Peterson LR. Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance. Clin Microbiol Infect. 2005;11(Suppl 5):4–16.PubMedCrossRef Peterson LR. Squeezing the antibiotic balloon: the impact of antimicrobial classes on emerging resistance. Clin Microbiol Infect. 2005;11(Suppl 5):4–16.PubMedCrossRef
15.
go back to reference Cals JW, Butler CC, Hopstaken RM, Hood K, Dinant GJ. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. Bmj. 2009;338:b1374.PubMedCrossRef Cals JW, Butler CC, Hopstaken RM, Hood K, Dinant GJ. Effect of point of care testing for C reactive protein and training in communication skills on antibiotic use in lower respiratory tract infections: cluster randomised trial. Bmj. 2009;338:b1374.PubMedCrossRef
16.
go back to reference Francis NA, Butler CC, Hood K, Simpson S, Wood F, Nuttall J. Effect of using an interactive booklet about childhood respiratory tract infections in primary care consultations on reconsulting and antibiotic prescribing: a cluster randomised controlled trial. Bmj. 2009;339:b2885.PubMedCrossRef Francis NA, Butler CC, Hood K, Simpson S, Wood F, Nuttall J. Effect of using an interactive booklet about childhood respiratory tract infections in primary care consultations on reconsulting and antibiotic prescribing: a cluster randomised controlled trial. Bmj. 2009;339:b2885.PubMedCrossRef
17.
go back to reference CA McNulty, GM Lasseter, A Charlett, A Lovering, R Howell-Jones, A Macgowan, et al. Does laboratory antibiotic susceptibility reporting influence primary care prescribing in urinary tract infection and other infections? J Antimicrob Chemother. 2011;66(6):1396–1404. CA McNulty, GM Lasseter, A Charlett, A Lovering, R Howell-Jones, A Macgowan, et al. Does laboratory antibiotic susceptibility reporting influence primary care prescribing in urinary tract infection and other infections? J Antimicrob Chemother. 2011;66(6):1396–1404.
18.
go back to reference Jiang HJ, Lagasse RS, Ciccone K, Jakubowski MS, Kitain EM. Factors influencing hospital implementation of acute pain management practice guidelines. J Clin Anesth. 2001;13(4):268–76.PubMedCrossRef Jiang HJ, Lagasse RS, Ciccone K, Jakubowski MS, Kitain EM. Factors influencing hospital implementation of acute pain management practice guidelines. J Clin Anesth. 2001;13(4):268–76.PubMedCrossRef
19.
go back to reference Christakis DA, Rivara FP. Pediatricians’awareness of and attitudes about four clinical practice guidelines. Pediatrics. 1998;101(5):825–30.PubMedCrossRef Christakis DA, Rivara FP. Pediatricians’awareness of and attitudes about four clinical practice guidelines. Pediatrics. 1998;101(5):825–30.PubMedCrossRef
20.
go back to reference Costanza ME, Stoddard AM, Zapka JG, Gaw VP, Barth R. Physician compliance with mammography guidelines: barriers and enhancers. J Am Board Fam Pract. 1992;5(2):143–52.PubMed Costanza ME, Stoddard AM, Zapka JG, Gaw VP, Barth R. Physician compliance with mammography guidelines: barriers and enhancers. J Am Board Fam Pract. 1992;5(2):143–52.PubMed
Metadata
Title
Impact of a region wide antimicrobial stewardship guideline on urinary tract infection prescription patterns
Authors
Celine Slekovec
Joël Leroy
Nathalie Vernaz-Hegi
Jean-Pierre Faller
Danièle Sekri
Bruno Hoen
Daniel Talon
Xavier Bertrand
Publication date
01-04-2012
Publisher
Springer Netherlands
Published in
International Journal of Clinical Pharmacy / Issue 2/2012
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-012-9606-6

Other articles of this Issue 2/2012

International Journal of Clinical Pharmacy 2/2012 Go to the issue